Altered serum adiponectin and interleukin-8 levels are associated in the pathophysiology of major depressive disorder: A case-control study
- PMID: 36409748
- PMCID: PMC9678262
- DOI: 10.1371/journal.pone.0276619
Altered serum adiponectin and interleukin-8 levels are associated in the pathophysiology of major depressive disorder: A case-control study
Abstract
Background: Major depressive disorder (MDD) is a complex mental health condition that results in several obstacles including disabilities, loss of productivity, and economic burdens on both patients and society. Etiopathogenesis of MDD involves several factors such as sociodemographic, genetic, and biological determinants. However, any suitable biomarkers for risk assessment of depression have not been established yet. Alterations of cytokine are assumed to be involved in the pathophysiology and severity of the depressive disorder. Therefore, we aimed to evaluate serum adiponectin and interleukin-8 (IL-8) among MDD patients in Bangladesh.
Methods: We recruited a total of 63 MDD patients and 94 age-sex matched healthy controls (HCs) in the present study. MDD patients were enrolled from a tertiary care teaching hospital, Dhaka, Bangladesh, and HCs from surrounding parts of Dhaka city. A psychiatrist assessed all the study participants following the criteria mentioned in the DSM-5. We applied the Hamilton depression (Ham-D) rating scale to assess the depression severity. Serum adiponectin and IL-8 levels were determined using ELISA kits (BosterBio, USA).
Results: The mean serum concentration of adiponectin was decreased (30.67±4.43 μg/mL vs. 53.81±5.37 μg/mL), and the IL-8 level was increased (160.93±14.84 pg/mL vs. 88.68±6.33 pg/mL) in MDD patients compared to HCs. Sex-specific scatters plot graphs showed the distribution of adiponectin and IL-8 levels with Ham-D scores in MDD patients. Also, ROC curve analysis demonstrated good predictive performances of serum adiponectin and IL-8 for MDD with the area under the curve (AUC) as 0.895 and 0.806, respectively.
Conclusion: The present study findings suggest that alterations of serum adiponectin and IL-8 levels in MDD patients might be involved in the disease process. Therefore, we can use these changes of cytokines in serum levels as early risk assessment tools for depression. The present study findings should be considered preliminary. We propose further interventional studies to evaluate the exact role of adiponectin and IL-8 in depression.
Copyright: © 2022 Islam et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



Similar articles
-
Altered IL-3 and lipocalin-2 levels are associated with the pathophysiology of major depressive disorder: a case-control study.BMC Psychiatry. 2023 Nov 13;23(1):830. doi: 10.1186/s12888-023-05354-y. BMC Psychiatry. 2023. PMID: 37957650 Free PMC article.
-
Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: A case-control study.PLoS One. 2023 Jul 3;18(7):e0288159. doi: 10.1371/journal.pone.0288159. eCollection 2023. PLoS One. 2023. PMID: 37399205 Free PMC article.
-
Evaluation of serum interleukin-12 and interleukin-4 as potential biomarkers for the diagnosis of major depressive disorder.Sci Rep. 2024 Jan 18;14(1):1652. doi: 10.1038/s41598-024-51932-9. Sci Rep. 2024. PMID: 38238514 Free PMC article.
-
Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.Acta Psychiatr Scand. 2017 May;135(5):373-387. doi: 10.1111/acps.12698. Epub 2017 Jan 25. Acta Psychiatr Scand. 2017. PMID: 28122130
-
Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.Mol Psychiatry. 2020 Feb;25(2):339-350. doi: 10.1038/s41380-019-0474-5. Epub 2019 Aug 19. Mol Psychiatry. 2020. PMID: 31427752
Cited by
-
Altered serum TNF-α and MCP-4 levels are associated with the pathophysiology of major depressive disorder: A case-control study results.PLoS One. 2023 Nov 15;18(11):e0294288. doi: 10.1371/journal.pone.0294288. eCollection 2023. PLoS One. 2023. PMID: 37967104 Free PMC article.
-
Higher serum interleukin-12 levels are associated with the pathophysiology of major depressive disorder: A case-control study results.Health Sci Rep. 2022 Dec 24;6(1):e1005. doi: 10.1002/hsr2.1005. eCollection 2023 Jan. Health Sci Rep. 2022. PMID: 36582626 Free PMC article.
-
Altered IL-3 and lipocalin-2 levels are associated with the pathophysiology of major depressive disorder: a case-control study.BMC Psychiatry. 2023 Nov 13;23(1):830. doi: 10.1186/s12888-023-05354-y. BMC Psychiatry. 2023. PMID: 37957650 Free PMC article.
-
Evaluation of inflammatory cytokines in drug-naïve major depressive disorder: A systematic review and meta-analysis.Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231198828. doi: 10.1177/03946320231198828. Int J Immunopathol Pharmacol. 2023. PMID: 37625799 Free PMC article.
-
Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: A case-control study.PLoS One. 2023 Jul 3;18(7):e0288159. doi: 10.1371/journal.pone.0288159. eCollection 2023. PLoS One. 2023. PMID: 37399205 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources